Are EDS Treatments Moving Faster Than the Evidence? with Dr. Dacre Knight (Ep 207)

0:00-34:14

Are surgical risks in EDS exaggerated, underestimated, or simply misunderstood? And how can patients tell the difference between a promising treatment and an expensive procedure being marketed ahead of the evidence? In this listener Q&A episode, host Dr. Linda Bluestein, the Hypermobility MD, is joined by recurring co-host Dr. Dacre Knight, Medical Director of the UVA Health EDS and Hypermobility Disorders Center, to tackle some of the most difficult questions submitted by the Bendy Bodies community. They begin with a candid discussion about surgery in EDS: why most patients do well, which complications are genuinely more likely, and why a surgeon’s technical experience and procedural volume may matter just as much as their understanding of EDS (Ehlers-Danlos Syndromes) and HSD (Hypermobility Spectrum Disorders). They also explain how poorly controlled mast cell activation can derail recovery and why preparation before surgery may be more important than simply being reassured that everything will be fine. The conversation then turns to the striking mental health burden within the EDS and hypermobility population, including self-harm and cutting behaviors. Dr. Bluestein and Dr. Knight discuss why anxiety, depression, insomnia, and pain may sometimes reflect shared underlying biological drivers, and how treatments such as low dose naltrexone (LDN) may improve multiple symptoms at once when used thoughtfully.

Publisher

Bendy Bodies with Dr. Linda Bluestein

Published

July 30, 2026

Duration

34 min

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

Dr. Linda Bluestein

BB

Bendy Bodies with Dr. Linda Bluestein

@bendybodieswithdrlindabluest

#edstreatmentsmoving #evidence #dacreknight #medicine #selfimprovement

The Nile